Previous published studies have demonstrated an increased lipogenesis and a decreased fatty acid β-oxidation in hepatic steatosis and these processes are tightly controlled by a number of genes including CPT-1a and PARs such as PPARα. This evidence concerns the gene CPT1A and fatty liver disease.